Tag:
anaplastic large cell lymphoma
Latest Headlines
Latest Headlines
UPDATED: FDA pins approval on Seattle Genetics' cancer drug Adcetris
Seattle Genetics ( $SGEN ) has crossed the finish line. The FDA has granted the biotech an accelerated approval for Adcetris to treat Hodgkin's lymphoma and anaplastic large cell lymphoma. While it's
UPDATED: Seattle Genetics lymphoma drug gets FDA panel nod
Seattle Genetics ( $SGEN ) can claim a victory today. An FDA panel of experts voted unanimously for accelerated approval of the developer's drug brentuximab vedotin (Adcetris) for patients with
